Edwards Lifesciences Corporation (EW)
Bolsa Mexicana de Valores · Mexico · prices in MXN · close of 27 Oct 2026
Key indicators
| Last close | MXN 2,344.43 |
|---|---|
| 52-week range | 1,340.70 – 2,359.49 |
| Return, 1 month / 3 months | +52.5% / +60.9% |
| Return, 1 year / 3 years | +70.9% / +92.7% |
| Trend | Uptrend |
| RSI (14) | 94 |
| Volatility (1 year) | 43.7% |
| Worst drawdown (1 year) | -15.4% |
| Average daily value traded | 0.80M MXN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Edwards Lifesciences Corporation develops medical devices for heart disease, with a focus on heart valves and haemodynamic monitoring. The company makes surgical and transcatheter heart valve systems used to treat conditions such as aortic stenosis, along with critical care monitoring products that help clinicians track blood flow and pressure. Its customers are hospitals, cardiac surgeons and cardiologists. Edwards Lifesciences is based in Irvine, California, in the United States.
Edwards Lifesciences Corporation trades under the code EW on the Bolsa Mexicana de Valores in Mexico, with its price quoted in Mexican pesos (MXN). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Edwards Lifesciences Corporation (EW) trades on the Bolsa Mexicana de Valores in Mexico. It last closed at MXN 2,344.43 on 27 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 37 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 70.9% and over the last three months it rose 60.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bolsa Mexicana de Valores
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 89 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 54.7% | ||
| From 52-week high | -0.5% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 60.9% | ||
| 6-month return | 62.8% | ||
| 12-month return, skipping the last month | 12.1% | ||
| Stability (higher is calmer) | 48 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.4% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.80M MXN | ||
| Zero-volume days | 90.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +52.5% |
| 3 months | +60.9% |
| 6 months | +62.8% |
| 1 year | +70.9% |
| 3 years | +92.7% |
| 5 years | −0.1% |
Signals
| 50-day / 200-day average | 1,671.15 / 1,515.26 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 46.77 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bolsa Mexicana de Valores; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.